Atlas Molecular Pharma
Contact information
Atlas Molecular Pharma
Cristina Garrido - COO
Parque Tecnológico de Bizkaia
Derio - 48160
Bizkaia
+34 688 849 117
Areas of activities
- Drug development
- Drug discovery
- Genetic and rare diseases
Atlas Molecular Pharma develops innovative therapies for ultra-rare diseases by combining scientific excellence, intelligent drug repurposing, efficient clinical development, and the design of disease-specific pharmacological chaperones to address shared pathogenic mechanisms. Our approach will accelerate patient access to meaningful treatments and improve quality of life for patients and the families who support them.
Products and services
I+D
Investigational Medicinal products in development for the treatment of rare and ultra-rare diseases
Areas of interest for future collaborations
Non-clinical Development
Clinical Development
Regulatory Affairs
Market Access
Biotech Sanitaria
| Product / Service | Type | Therapeutic area | Development phase |
|---|---|---|---|
| ATL-003: Prion Disease | Biodrugs/ Drugs | Enfermedades genéticas y raras | R&D |
| ATL-002: Tyrosinemia type I | Biodrugs/ Drugs | Enfermedades genéticas y raras | Preclinical |
| ATL-001b: Porphyria Cutanea Tarda (PCT) | Biodrugs/ Drugs | Enfermedades genéticas y raras | R&D |
| ATL-001: Congenital Erythropoietic Porphyria (CEP) | Biodrugs/ Drugs | Enfermedades genéticas y raras | P II |